SCHEMBL9894424

SCHEMBL9894424

C#CCCOCC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6438042 0.86
SCHEMBL13913111 0.82 MEN1 (0.35)
SCHEMBL9733357 0.81
SCHEMBL28911560 0.80 CA1 (0.52)
SCHEMBL31646764 0.78 POLB (0.39)
SCHEMBL9733360 0.76
SCHEMBL12629272 0.76 POLB (0.38)
SCHEMBL25755541 0.75
SCHEMBL4278769 0.75
SCHEMBL26236318 0.75 TSHR (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023514-B2 Odorants of the violet type FIRMENICH SA (CH) 2018-07-17 US disclosed
EP-2928995-B1 ODORANTS OF THE VIOLET TYPE FIRMENICH & CIE (CH) 2016-08-24 EP disclosed
US-20150315516-A1 ODORANTS OF THE VIOLET TYPE FIRMENICH SA (CH) 2015-11-05 US disclosed
EP-2491032-B1 AKT INHIBITORS LILLY CO ELI (US) 2014-04-16 EP disclosed
EP-2491032-B1 AKT INHIBITORS LILLY CO ELI (US) 2014-04-16 EP disclosed
US-8436002-B2 AKT inhibitors ELI LILLY AND COMPANY (US) 2013-05-07 US disclosed
US-8436002-B2 AKT inhibitors ELI LILLY AND COMPANY (US) 2013-05-07 US disclosed
US-8436002-B2 AKT inhibitors ELI LILLY AND COMPANY (US) 2013-05-07 US disclosed
US-20120149684-A1 AKT INHIBITORS ELI LILLY AND COMPANY (US) 2012-06-14 US disclosed
US-20120149684-A1 AKT INHIBITORS ELI LILLY AND COMPANY (US) 2012-06-14 US disclosed
US-20120149684-A1 AKT INHIBITORS ELI LILLY AND COMPANY (US) 2012-06-14 US disclosed